000			01911 a2200529 4500
005			20250514042845.0
264		0	_c20021126
008			200211s 0 0 eng d
022			_a0306-4522
024	7		_a10.1016/s0306-4522(02)00214-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aDass, B
245	0	0	_aBehavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. _h[electronic resource]
260			_bNeuroscience _c2002
300			_a99-109 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBody Weight _xdrug effects
650	0	4	_aCallithrix _xanatomy & histology
650	0	4	_aCell Count
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDrug Interactions _xphysiology
650	0	4	_aFemale
650	0	4	_aGlial Fibrillary Acidic Protein _xmetabolism
650	0	4	_aHedgehog Proteins
650	0	4	_aImmunohistochemistry
650	0	4	_aLevodopa _xpharmacology
650	0	4	_aMale
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aNerve Growth Factors _xpharmacology
650	0	4	_aNerve Regeneration _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aParkinsonian Disorders _xdrug therapy
650	0	4	_aRecovery of Function _xdrug effects
650	0	4	_aSubstantia Nigra _xdrug effects
650	0	4	_aTrans-Activators _xpharmacology
650	0	4	_aTreatment Outcome
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
700	1		_aIravani, M M
700	1		_aJackson, M J
700	1		_aEngber, T M
700	1		_aGaldes, A
700	1		_aJenner, P
773	0		_tNeuroscience _gvol. 114 _gno. 1 _gp. 99-109
856	4	0	_uhttps://doi.org/10.1016/s0306-4522(02)00214-2 _zAvailable from publisher's website
999			_c12088918 _d12088918